-+ 0.00%
-+ 0.00%
-+ 0.00%

BTIG Reiterates Buy on NRX Pharmaceuticals, Maintains $10 Price Target

Benzinga·09/14/2026 18:40:25
Listen to the news
BTIG analyst Thomas Shrader reiterates NRX Pharmaceuticals (NASDAQ:NRXP) with a Buy and maintains $10 price target.